EUVIMEDEUVIMED entdecken
QuerschnittstudieOpen Access · CC BY 4.0

Seamless trials in oncology: A cross-sectional analysis of characteristics and reporting

Katarzyna Klas iD, Karolina Strzebonska, Paola Buedo, Alicja Włodarczyk, Samuel Gordon, Paulina Kaszuba, Maciej Polak, Marcin Waligora iD

PLOS ONE · 03.12.2024 · 19 (12) · e0312797

DOI: 10.1371/journal.pone.0312797 ↗

Kurz gefasst

Querschnittstudie in der Zeitschrift PLOS ONE, online erschienen am 03.12.2024. Verfasst von Katarzyna Klas und 7 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Health Sciences, Research Ethics in Medicine Study Group (REMEDY), Jagiellonian University Medical College, Krakow, Poland. Hauptthemen laut MEDLINE: Medical Oncology, Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science Center, Strategic Programme Excellence Initiative of the Jagiellonian University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Seamless clinical trials have received much attention as a possible way to expedite drug development. The growing importance of seamless design can be seen in oncology research, especially in the early stages of drug development. Our objective is to examine the basic characteristics of seamless early-phase oncology trials registered on the ClinicalTrials.gov database and to determine their results reporting rates. We also aim to identify factors associated with results reporting.

Methods

Cross-sectional study. We defined seamless early-phase trials as either those registered as Phase 1/2 or Phase 1 with planned expansion cohort(s). Using the ClinicalTrials.gov registry, we searched for interventional cancer clinical trials with primary completion date (PCD) between 2016 and 2020. After trial selection, we performed manual data extraction based on the trial record description and the results posted in the trial registry. We used logistic regression to search for predictors of results reporting. Protocol: https://osf.io/m346x/ .

Results

We included 1051 seamless early-phase oncology trials reported as completed (PCD) between 2016 and 2020. We provided descriptive statistics including the number of patients enrolled, study start date, primary completion date, funding, type of intervention, cancer type, design details, type of endpoints, recruitment regions, and number of trial sites. Overall, only 34.7% trials reported results on ClinicalTrials.gov. The results reporting rates for 24 months was 24.0%. The overall reporting rate for Phase 1/2 studies was over three times higher than for seamless Phase 1.

Conclusions

Our study provides cross-sectional data on seamless early-phase oncology trials registered on ClinicalTrials.gov. We highlight the challenges of the evolving clinical trial design landscape and the problem of missing results in the seamless design context, which raises serious ethical concerns. Efforts should be made to adapt the functionality of the ClinicalTrials.gov database to emerging clinical trial models.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Medical OncologyNeoplasmsHumansCross-Sectional StudiesClinical Trials as TopicRegistriesResearch DesignClinical Trials, Phase I as TopicDatabases, FactualClinical Trials, Phase II as Topic

Autor:innen und Institutionen

  • Faculty of Health Sciences, Research Ethics in Medicine Study Group (REMEDY), Jagiellonian University Medical College, Krakow, Poland.
  • Doctoral School of Medical and Health Sciences, Jagiellonian University Medical College, Krakow, Poland.
  • Faculty of Health Sciences, Department of Epidemiology and Population Studies, Institute of Public Health, Jagiellonian University Medical College, Krakow, Poland.

ORCID-Profile: Katarzyna Klas, Marcin Waligora

Förderung

  • National Science Center
  • Strategic Programme Excellence Initiative of the Jagiellonian University

Zitieren

APA

Klas, K., Strzebonska, K., Buedo, P., Włodarczyk, A., Gordon, S., Kaszuba, P., Polak, M., & Waligora, M. (2024). Seamless trials in oncology: A cross-sectional analysis of characteristics and reporting. PLOS ONE, 19(12), e0312797. https://doi.org/10.1371/journal.pone.0312797

Vancouver

Klas K, Strzebonska K, Buedo P, Włodarczyk A, Gordon S, Kaszuba P, et al. Seamless trials in oncology: A cross-sectional analysis of characteristics and reporting. PLOS ONE. 2024;19(12):e0312797. doi:10.1371/journal.pone.0312797

BibTeX
@article{Klas2024,
  author = {Klas, Katarzyna and Strzebonska, Karolina and Buedo, Paola and Włodarczyk, Alicja and Gordon, Samuel and Kaszuba, Paulina and Polak, Maciej and Waligora, Marcin},
  title = {Seamless trials in oncology: A cross-sectional analysis of characteristics and reporting},
  journal = {PLOS ONE},
  year = {2024},
  volume = {19},
  number = {12},
  pages = {e0312797},
  doi = {10.1371/journal.pone.0312797}
}
Kostenlos starten →